Lower cost Asian JE vaccine in prospect as Inviragen licenses cell tech to Vietnam producer

07 Jan 2013

The US vaccines firm Inviragen has started off the new year on the right foot by meeting one of the main goals for its cell cultured Japanese encephalitis (JE) vaccine: to partner the program with a local manufacturer in an endemic region.

A new agreement gives the state-owned Vietnamese vaccines producer VABIOTECH (The Company for Vaccine and Biological Production No 1) exclusive...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Lilly Looks For Muscle-Sparing Candidates In Pact With Juvena

12 Jun 2025

• By Joseph Haas

Deal Snapshot: Including its internal efforts with bimagrumab, Lilly has been seeking a muscle-sparing therapy to complement GLP-1 obesity drugs, such as Zepbound.